Eight Tower Bridge
161 Washington Street #1400
Current: WALGREEN CO: CHIEF MEDICAL OFFICER
2009 SymCare Personalized Health Solutions, Inc.: General Manager and Chief Medical Officer P&L responsibility for division. Responsible for all clinical and commercial activities, product expansion, integration and operations.
2007 - 2009 SymCare Personalized Health Solutions, Inc.: Chief Medical Officer/Head of Strategy
Responsible for strategic planning, links to product development and marketing, medical affairs, conduct of clinical trials, clinical financial outcomes and external communications.
2005 - 2010 American Heart Association, Founder’s Affiliate: Chair, Health Disparities Taskforce
Responsible for strategic development of initiatives, implementation and outcomes evaluation.
2003 - 2006 Aetna, Inc.: National Medical Director /Clinical Product Head
Earned promotion to develop, prioritize and articulate Aetna’s medical management strategy.
National Medical Director/Clinical Program Development, Marketing and Sales
Developed comprehensive programs for Whole Member Management. Oversaw wellness offerings including coaching and advocacy/obesity management, worksite screenings and immunizations. Instituted the use of incentives/discounts/rewards for behavior change. Introduced comprehensive disease management programs – high touch and “lite” DM offerings – personalized to gender/ethnicity/age demographics: operational design, strategic partnerships, business case, outcomes analysis and reporting. Delivered numerous presentations to sales, business brokers, academic and government organizations.
National Medical Director for Women’s Health
Launched new programs across a woman’s lifespan and addressed health disparities in maternity, mammography and heart disease. Designed study evaluation, monitored, and presented data of maternity program outcomes. Integrated Women’s Health with Disease Management.
2010 Pegus, Cheryl, Guattery, Deborah et. al. A Randomized Clinical Trial of a Remote Monitoring Technology in a Disease Management Setting : Interim results from the Diabetes Remote Monitoring Evaluation (DREME) Study. Abstract presentation at ATA. May, 2010
2009 Eslava, Sergio, Pegus, Cheryl et. al. Usability of a Novel Diabetes Risk Stratification Tool. Presented at the Diabetes Technology Society Conference. San Francisco, CA November, 2009
2009 Guattery, Deborah, Pegus, Cheryl et. al. The Important Role of the Health Care Provider During a Human Factors Trial When Developing a New Remote Monitoring Device for Self-Management of Diabetes. Presented at IDF, Montreal 2009
2009 Eslava, Sergio, Pegus, Cheryl et. al. Perception of Clinical Usefulness and Relevance of a Novel Diabetes Risk Stratification Tool by Clinicians. Presented at IDF, Montreal 2009
2009 Pegus, Cheryl, Menzin, Joseph et. al. Is Frequency of Self-Monitoring of Blood Glucose a Marker for Poorer Control in Type 2 Diabetes ? Poster presented at DMAA, Sept. 2009
2009 Kalenderian, Elsbeth, Pegus, Cheryl, Francis, Charles et. al. Cardiovascular Disease Urban Intevention : Baseline Activities and Findings. Journal of Community Health : Volume 34, Issue 4 (2009); page 282
2008 Pegus, Cheryl, Menzin, Joseph, Sussmam, Matthew et. Al. Insights in Subject Recruitment for Clinical Trials in Disease Management Settings; Preliminary data from the DREME study. Abstract presented at Diabetes Technology Society meeting
2008 Strategy Forum participant: A Plan for Action: Key Perspectives from the Racial/Ethnic Disparities Strategy Forum; King, Roderick et. al. the Disparities Solutions Center, Partners HealthCare System-Massachusetts General Hospital; Millbank Quarterly, Vol. 86, No. 2, 2008 (pp.241-272)